© Reuters. Abbott Labs earnings beat by $0.11, revenue topped estimates
Investing.com – Abbott Labs (NYSE: ABT) reported fourth quarter EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1B versus the consensus estimate of $9.62B.
Abbott Labs sees FY 2023 EPS of $4.30-$4.50 versus the analyst consensus of $4.40.
Abbott Labs’s stock price closed at $112.53. It is up 13.11% in the last 3 months and down -6.28% in the last 12 months.
Abbott Labs saw 4 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Abbott Labs’s stock price’s past reactions to earnings here.
According to InvestingPro, Abbott Labs’s Financial Health score is “great performance“.
Check out Abbott Labs’s , and Abbott Labs’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar